Imidazole Piperazines: Sar and Development of a Potent Class of Cyclin-Dependent Kinase Inhibitors with a Novel Binding Mode.
Finlay, M.R., Acton, D.G., Andrews, D.M., Barker, A.J., Dennis, M., Fisher, E., Graham, M.A., Green, C.P., Heaton, D.W., Karoutchi, G., Loddick, S.A., Morgentin, R., Roberts, A., Tucker, J.A., Weir, H.M.(2008) Bioorg Med Chem Lett 18: 4442
- PubMed: 18617397 
- DOI: 10.1016/j.bmcl.2008.06.027
- Primary Citation of Related Structures:  
2VV9 - PubMed Abstract: 
A piperazine series of cyclin-dependent kinase (CDK) inhibitors have been identified. The compounds exhibit excellent physiochemical properties and a novel binding mode, whereby a bridging interaction via a water molecule with Asp 86 of CDK2, leads to selectivity for the CDK family of enzymes over other kinases ...